Abiomed Passes Midway Point Of AbioCor Trial With Eighth Implant

Eight Abiomed AbioCor total artificial hearts have been implanted as of Jan. 7, marking the halfway-point of the company's clinical trial to support a PMA application in 2004

More from Archive

More from Medtech Insight